Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

High risk of HIV-related mortality is associated with selenium deficiency.

Baum MK, Shor-Posner G, Lai S, Zhang G, Lai H, Fletcher MA, Sauberlich H, Page JB.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Aug 15;15(5):370-4.

PMID:
9342257
2.

Micronutrients and HIV-1 disease progression.

Baum MK, Shor-Posner G, Lu Y, Rosner B, Sauberlich HE, Fletcher MA, Szapocznik J, Eisdorfer C, Buring JE, Hennekens CH.

AIDS. 1995 Sep;9(9):1051-6.

PMID:
8527077
3.

Mortality risk in selenium-deficient HIV-positive children.

Campa A, Shor-Posner G, Indacochea F, Zhang G, Lai H, Asthana D, Scott GB, Baum MK.

J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 15;20(5):508-13.

PMID:
10225235
4.

Role of micronutrients in HIV-infected intravenous drug users.

Baum MK.

J Acquir Immune Defic Syndr. 2000 Oct 1;25 Suppl 1:S49-52. Review.

PMID:
11126427
5.

Zinc status in human immunodeficiency virus type 1 infection and illicit drug use.

Baum MK, Campa A, Lai S, Lai H, Page JB.

Clin Infect Dis. 2003;37 Suppl 2:S117-23.

PMID:
12942385
6.

Selenium status is associated with accelerated HIV disease progression among HIV-1-infected pregnant women in Tanzania.

Kupka R, Msamanga GI, Spiegelman D, Morris S, Mugusi F, Hunter DJ, Fawzi WW.

J Nutr. 2004 Oct;134(10):2556-60.

7.

Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand.

Wannamethee SG, Sirivichayakul S, Phillips AN, Ubolyam S, Ruxrungtham K, Hanvanich M, Phanuphak P.

Int J Epidemiol. 1998 Apr;27(2):289-95.

PMID:
9602412
8.

Size and duration of zidovudine benefit in 1003 HIV-infected patients: U.S. Army, Navy, and Air Force natural history data. Military Medical Consortium for Applied Retroviral Research.

Gardner LI, Harrison SH, Hendrix CW, Blatt SP, Wagner KF, Chung RC, Harris RW, Cohn DL, Burke DS, Mayers DL.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Apr 1;17(4):345-53.

PMID:
9525436
9.

Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.

Bedell R, Heath KV, Hogg RS, Wood E, Press N, Yip B, O'Shaughnessy MV, Montaner JS.

Antivir Ther. 2003 Oct;8(5):379-84.

PMID:
14640384
10.

Update on vitamins, minerals, and the carotenoids.

Coodley G.

J Physicians Assoc AIDS Care. 1995 Jan;2(1):24-9.

PMID:
11362198
11.

Plasma zinc, copper, copper:zinc ratio, and survival in a cohort of HIV-1-infected homosexual men.

Lai H, Lai S, Shor-Posner G, Ma F, Trapido E, Baum MK.

J Acquir Immune Defic Syndr. 2001 May 1;27(1):56-62.

PMID:
11404521
12.

Impact of selenium status on the pathogenesis of mycobacterial disease in HIV-1-infected drug users during the era of highly active antiretroviral therapy.

Shor-Posner G, Miguez MJ, Pineda LM, Rodriguez A, Ruiz P, Castillo G, Burbano X, Lecusay R, Baum M.

J Acquir Immune Defic Syndr. 2002 Feb 1;29(2):169-73.

PMID:
11832687
13.

Reduced mortality and CD4 cell loss among carriers of the interleukin-10 -1082G allele in a Zimbabwean cohort of HIV-1-infected adults.

Erikstrup C, Kallestrup P, Zinyama-Gutsire RB, Gomo E, Butterworth AE, Pedersen BK, Ostrowski SR, Gerstoft J, Ullum H.

AIDS. 2007 Nov 12;21(17):2283-91.

PMID:
18090276
14.

Relationships among nutritional status, disease progression, and survival in HIV infection.

Guenter P, Muurahainen N, Simons G, Kosok A, Cohan GR, Rudenstein R, Turner JL.

J Acquir Immune Defic Syndr. 1993 Oct;6(10):1130-8.

PMID:
8105073
15.

Specific nutrient abnormalities in asymptomatic HIV-1 infection.

Beach RS, Mantero-Atienza E, Shor-Posner G, Javier JJ, Szapocznik J, Morgan R, Sauberlich HE, Cornwell PE, Eisdorfer C, Baum MK.

AIDS. 1992 Jul;6(7):701-8.

PMID:
1503689
16.

Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.

Lapadula G, Torti C, Maggiolo F, Casari S, Suter F, Minoli L, Pezzoli C, Di Pietro M, Migliorino G, Ouiros-Roldan E, Ladisa N, Sighinolfi L, Costarelli S, Carosi G; Italian MASTER Cohort.

Antivir Ther. 2007;12(6):941-7.

PMID:
17926648
17.

Thrombocytopenia in HIV-infected drug users in the HAART era.

Burbano X, Miguez MJ, Lecusay R, Rodriguez A, Ruiz P, Morales G, Castillo G, Baum M, Shor-Posner G.

Platelets. 2001 Dec;12(8):456-61.

PMID:
11798394
18.

Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA study.

Miller V, Mocroft A, Reiss P, Katlama C, Papadopoulos AI, Katzenstein T, van Lunzen J, Antunes F, Phillips AN, Lundgren JD.

Ann Intern Med. 1999 Apr 6;130(7):570-7.

PMID:
10189326
19.

Selenium deficiency is associated with shedding of HIV-1--infected cells in the female genital tract.

Baeten JM, Mostad SB, Hughes MP, Overbaugh J, Bankson DD, Mandaliya K, Ndinya-Achola JO, Bwayo JJ, Kreiss JK.

J Acquir Immune Defic Syndr. 2001 Apr 1;26(4):360-4.

PMID:
11317079
20.

The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women's interagency HIV study.

Anastos K, Kalish LA, Hessol N, Weiser B, Melnick S, Burns D, Delapenha R, DeHovitz J, Cohen M, Meyer W, Bremer J, Kovacs A.

AIDS. 1999 Sep 10;13(13):1717-26. Erratum in: AIDS 2000 May 5;14(7):891.

PMID:
10509574

Supplemental Content

Support Center